Dairy Microbiology Division, National Dairy Research Institute, Karnal (Haryana), India.
Int J Food Sci Nutr. 2010 Aug;61(5):473-96. doi: 10.3109/09637480903455971.
Cancer is a serious global public health problem. Cancer incidence and mortality have been steadily rising throughout the past century in most places of the world. There are several epidemiological evidences that support a protective role of probiotics against cancer. Lactic acid bacteria and their probioactive cellular substances exert many beneficial effects in the gastrointestinal tract, and also release various enzymes into the intestinal lumen and exert potential synergistic (LAB) effects on digestion and alleviate symptoms of intestinal malabsorption. Consumption of fermented dairy products with LAB may elicit anti-tumor effects. These effects are attributed to the inhibition of mutagenic activity, the decrease in several enzymes implicated in the generation of carcinogens, mutagens, or tumor-promoting agents, suppression of tumors, and epidemiology correlating dietary regimes and cancer. Specific cellular components in lactic acid bacteria seem to induce strong adjuvant effects including modulation of cell-mediated immune responses, activation of the reticulo-endothelial system, augmentation of cytokine pathways, and regulation of interleukins and tumor necrosis factors. Studies on the effect of probiotic consumption on cancer appear promising, since recent in vitro and in vivo studies have indicated that probiotic bacteria might reduce the risk, incidence and number of tumors of the colon, liver and bladder. The protective effect against cancer development may be ascribed to binding of mutagens by intestinal bacteria, may suppress the growth of bacteria that convert procarcinogens into carcinogens, thereby reducing the amount of carcinogens in the intestine, reduction of the enzymes beta-glucuronidase and beta-glucosidase and deconjugation of bile acids, or merely by enhancing the immune system of the host. There are isolated reports citing that administration of LAB results in increased activity of anti-oxidative enzymes or by modulating circulatory oxidative stress that protects cells against carcinogen-induced damage. These include glutathione-S-transferase, glutathione, glutathione reductase, glutathione peroxidase, superoxide dismutase and catalase. However, there is no direct experimental evidence for cancer suppression in human subjects as a result of the consumption of probiotic cultures in fermented or unfermented dairy products, but there is a wealth of indirect evidence based largely on laboratory studies.
癌症是一个严重的全球公共卫生问题。在过去的一个世纪里,世界上大多数地方的癌症发病率和死亡率一直在稳步上升。有几项流行病学证据支持益生菌对癌症的保护作用。乳酸菌及其益生菌细胞物质在胃肠道中发挥许多有益作用,也将各种酶释放到肠腔中,并对消化产生潜在的协同作用(LAB),缓解肠道吸收不良的症状。食用含有乳酸菌的发酵乳制品可能会产生抗肿瘤作用。这些作用归因于抑制诱变活性、降低几种与致癌物、诱变剂或肿瘤促进剂生成有关的酶、抑制肿瘤以及与饮食和癌症相关的流行病学。乳酸菌中的特定细胞成分似乎会引起强烈的佐剂作用,包括调节细胞介导的免疫反应、激活网状内皮系统、增强细胞因子途径以及调节白细胞介素和肿瘤坏死因子。关于益生菌消费对癌症影响的研究似乎很有前景,因为最近的体外和体内研究表明,益生菌细菌可能降低结肠癌、肝癌和膀胱癌的风险、发病率和肿瘤数量。对癌症发展的保护作用可能归因于肠道细菌对诱变剂的结合,可能抑制将前致癌物转化为致癌物的细菌的生长,从而减少肠道中的致癌物数量,减少β-葡萄糖醛酸酶和β-葡萄糖苷酶的活性并使胆汁酸去结合,或者仅仅通过增强宿主的免疫系统。有孤立的报告称,LAB 的给药导致抗氧化酶的活性增加或通过调节循环氧化应激来保护细胞免受致癌物引起的损伤。这些包括谷胱甘肽-S-转移酶、谷胱甘肽、谷胱甘肽还原酶、谷胱甘肽过氧化物酶、超氧化物歧化酶和过氧化氢酶。然而,由于在发酵或未发酵的乳制品中食用益生菌培养物,没有直接的实验证据表明人类癌症得到抑制,但基于实验室研究的大量间接证据。